TTC Oncology to Present at Biotech Showcase(TM) Digital 2021
Chicago, Illinois--(Newsfile Corp. - January 13, 2021) - TTC Oncology ("TTC" or the "Company") CEO and CMO Arek Dudek, MD, PhD, will be participating in the Biotech Showcase virtual conference occurring January 11-15, 2021.
- Chicago, Illinois--(Newsfile Corp. - January 13, 2021) - TTC Oncology ("TTC" or the "Company") CEO and CMO Arek Dudek, MD, PhD, will be participating in the Biotech Showcase virtual conference occurring January 11-15, 2021.
- TTC Oncology CEO and CMO Arek Dudek, MD, PhD, will be participating in the Biotech Showcase virtual conference occurring January 11-15, 2021.
- TTC Oncology has completed a Phase I human clinical trial where TTC-352 was shown to have only minimal side effects.
- TTC Oncology is an emerging biotechnology company founded in 2015.